Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.40
Delayed Data
As of 4:00pm ET
 -0.03 / -2.10%
Today’s Change
0.84
Today|||52-Week Range
3.84
+3.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues9.5M0.000.000.00
 
 
Depreciation And Amortization693.0K1.2M852.0K692.0K
 
 
 
 
 
 
Operating ExpensesGross Income---1.2M-852.0K-692.0K
 
 
 
 
General Expenses51.3M21.2M22.4M9.8M
 
 
 
 
 
Research And Development41.0M14.3M14.7M4.0M
 
 
 
 
 
Total Operating Expenses52.0M22.3M23.2M10.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-42.5M-22.3M-23.2M-10.5M
 
 
 
 
 
Extraordinary Credit112.2M2.9M0.000.00
 
 
 
Extraordinary Charge-16.6M--0.000.00
 
 
Interest Expense On Debt307.0K305.0K304.0K302.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income53.0M-19.5M-22.9M-10.5M
 
 
 
 
 
Net Income51.9M-19.5M-22.9M-10.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.4M49.6M50.1M50.4M
 
 
 
 
 
Shares To Calculate EPS Diluted49.4M49.6M50.1M50.4M
 
 
 
 
 
 
Earnings Per ShareEPS$1.05-$0.39-$0.46-$0.21
 
 
 
 
 
EPS Diluted$1.05-$0.39-$0.46-$0.21